Year 2022 / Volume 114 / Number 5
Letter
MAFLD burden on the Spanish National Health System. A call to action

306-307

DOI: 10.17235/reed.2022.8606/2022

Daniel Riado Mínguez, María Luisa Gutiérrez García, Lorena Jara Fernández,

Abstract
We have read the editorial by Crespo et al on the metabolic associated liver disease (MAFLD) foreseeable burden on the Spanish National Health System over the next years. Between 0.35-0.4% of Spanish population has cirrhosis and more than one million people has significant fibrosis, assessed by ET ≥ 9 kPa. Compared with general population, patients with cirrhosis have more comorbidities and use healthcare resources more frequently. Recent data show a decrease of 24% in hospitalization due to cirrhosis during the period 2005-2014 in our country. These data predate the availability of direct antiviral agents against HCV. A 20% reduction of cirrhosis-related mortality during the period 2006-2018 was observed, as with other Southern European countries. This decline reflects a reduction of alcohol consumption in the last decades. More recently, 90% of patients with significant liver fibrosis were negative for HCV or HBV, did not consume harmful amounts of alcohol and showed components of metabolic syndrome thereby suggesting that MAFLD is the current leading cause of liver fibrosis in Spain. Some studies found that disadvantaged areas in the Community of Madrid had higher liver-related mortality, highlighting that lower income is another socioeconomic determinant of chronic liver disease.
Share Button
New comment
Comments

09/05/2022 19:05:46
EJUQX


References
1. Crespo J, Iruzubieta P, Lazarus JV. Can NAFLD overwhelm the Spanish healthcare system in the years to come? Rev Esp Enferm Dig. 2021 Dec 28;114:5-9. doi: 10.17235/reed.2021.8524/2021
2. Caballería L, Pera G, Arteaga I et al. High Prevalence of Liver Fibrosis Among European Adults With Unknown Liver Disease: A Population-Based Study. Clin Gastroenterol Hepatol 2018;16:1138-1145. doi: 10.1016/j.cgh.2017.12.048
3. Fernandez Rodriguez CM, Fernández Pérez C, Bernal JL et al. RECALAD. Patient care at National Health System Digestive Care Units - A pilot study, 2015. Rev Esp Enferm Dig. 2018 Jan;110(1):44-50. doi: 10.17235/reed.2017.5316/2017
4. Blachier M, Leleu H, Peck-Radosavljevic M et al. The burden of liver disease in Europe: A review of available epidemiological data. J Hepatol 2013; 58: 593-608 doi: 10.1016/j.jhep.2012.12.005
5. Segura del Pozo J, Gandarillas A , Domínguez Berjón F et al. Chronic liver disease and cirrhosis mortality and social deprivation: a spatial analysis in small areas of Madrid region. Nutr Hosp. 2010;25:597-605
Related articles

Editorial

Lights and shadows in the new definition of steatotic liver disease

DOI: 10.17235/reed.2024.10696/2024

Editorial

Treatment of portal vein thrombosis in cirrhosis patients

DOI: 10.17235/reed.2023.9800/2023

Editorial

AKI-HRS, more than a name change for type-1 hepatorenal syndrome

DOI: 10.17235/reed.2023.9677/2023

Letter

Budd-Chiari syndrome in Behçet’s disease

DOI: 10.17235/reed.2022.9267/2022

Editorial

New actors come into play against hepatitis delta

DOI: 10.17235/reed.2022.9050/2022

Letter

Hemoperitoneum due to rupture of intra-abdominal varices

DOI: 10.17235/reed.2022.8937/2022

Letter

Cirrhotic pattern in advanced hepatic sarcoidosis

DOI: 10.17235/reed.2021.8446/2021

Digestive Diseases Image

Giant cystic hepatocarcinoma in the absence of cirrhosis

DOI: 10.17235/reed.2021.8313/2021

Review

Physical frailty in liver transplantation

DOI: 10.17235/reed.2020.7448/2020

Review

Pyroptosis in liver disease

DOI: 10.17235/reed.2020.7034/2020

Review

Risk stratification and treatment of primary biliary cholangitis

DOI: 10.17235/reed.2018.5662/2018

Original

Colonic diverticulosis and the metabolic syndrome: an association?

DOI: 10.17235/reed.2017.5009/2017

Case Report

The clinical extremes of autoimmune cholangitis

DOI: 10.17235/reed.2017.4167/2015

Citation tools
Riado Mínguez D, Gutiérrez García M, Jara Fernández L. MAFLD burden on the Spanish National Health System. A call to action. 8606/2022


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 1158 visits.
This article has been downloaded 73 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 15/01/2022

Accepted: 19/01/2022

Online First: 21/01/2022

Published: 06/05/2022

Article Online First time: 6 days

Article editing time: 111 days


Share
This article has been rated by 1 readers.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology